Huikwang Corporation (TPEX:6508)
Taiwan · Delayed Price · Currency is TWD 25.70
-0.10 (-0.39%)
Aug 14, 2025, 11:50 AM CST
G1 Therapeutics Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 85.04 | 92.57 | 90.92 | 314.46 | 329.08 | 189.19 | Upgrade |
Depreciation & Amortization | 51.43 | 52.21 | 55.97 | 55.73 | 53.99 | 62.99 | Upgrade |
Other Amortization | 0.15 | 0.16 | 0.18 | 0.11 | 0.12 | 0.11 | Upgrade |
Loss (Gain) From Sale of Assets | -0.25 | -0.24 | -0.23 | 0.17 | -258.92 | 7.51 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 11.49 | - | Upgrade |
Provision & Write-off of Bad Debts | 4.04 | 4.7 | -4.49 | 15.19 | 2.7 | 8.47 | Upgrade |
Other Operating Activities | -23.69 | -17.41 | -59.95 | -12.59 | 11.87 | 19.62 | Upgrade |
Change in Accounts Receivable | -60.55 | -15.84 | 313.34 | -230.06 | -231.35 | 23.7 | Upgrade |
Change in Inventory | 65.48 | 52.97 | -58.85 | -19.61 | -78.01 | -2.24 | Upgrade |
Change in Accounts Payable | 27.91 | 56.81 | -19.38 | -27.39 | 32.43 | -37.31 | Upgrade |
Change in Unearned Revenue | 9.58 | 20.46 | 22.52 | 13.86 | 16.18 | -13.14 | Upgrade |
Change in Other Net Operating Assets | -22.17 | -34.62 | 98.39 | 26.25 | 23.68 | -67.55 | Upgrade |
Operating Cash Flow | 136.98 | 211.78 | 438.42 | 136.12 | -86.76 | 191.33 | Upgrade |
Operating Cash Flow Growth | -24.03% | -51.70% | 222.09% | - | - | -58.18% | Upgrade |
Capital Expenditures | -29.44 | -31.42 | -19.14 | -16.24 | -17.1 | -109.12 | Upgrade |
Sale of Property, Plant & Equipment | 0.26 | 0.24 | 6.49 | - | 0.2 | 0.64 | Upgrade |
Sale (Purchase) of Intangibles | - | - | -0.41 | - | -0.16 | - | Upgrade |
Investment in Securities | -84.2 | 6.06 | -9.15 | 165.31 | -190.49 | 156.08 | Upgrade |
Other Investing Activities | -1.66 | -3.49 | 7.16 | -7.93 | 146.18 | 149.6 | Upgrade |
Investing Cash Flow | -115.04 | -28.6 | -15.06 | 141.14 | -61.36 | 197.2 | Upgrade |
Short-Term Debt Issued | - | 378.11 | 1,501 | 110 | 369 | 860 | Upgrade |
Total Debt Issued | 358.11 | 378.11 | 1,501 | 110 | 369 | 860 | Upgrade |
Short-Term Debt Repaid | - | -435.11 | -1,629 | -99 | -510 | -810 | Upgrade |
Long-Term Debt Repaid | - | -0.78 | - | - | - | - | Upgrade |
Total Debt Repaid | -413.37 | -435.9 | -1,629 | -99 | -510 | -810 | Upgrade |
Net Debt Issued (Repaid) | -55.25 | -57.78 | -128.95 | 11 | -141 | 50 | Upgrade |
Common Dividends Paid | -86.54 | -86.54 | -232.37 | -257.01 | -136.48 | -152.61 | Upgrade |
Other Financing Activities | - | - | -0.22 | -0.99 | 1.19 | -0.77 | Upgrade |
Financing Cash Flow | -141.79 | -144.32 | -361.53 | -247.01 | -276.28 | -103.38 | Upgrade |
Foreign Exchange Rate Adjustments | 13.41 | 16.25 | -8.87 | 8.8 | -9.68 | 5.61 | Upgrade |
Net Cash Flow | -106.44 | 55.11 | 52.96 | 39.05 | -434.09 | 290.75 | Upgrade |
Free Cash Flow | 107.54 | 180.36 | 419.28 | 119.88 | -103.85 | 82.21 | Upgrade |
Free Cash Flow Growth | -32.05% | -56.98% | 249.75% | - | - | -74.41% | Upgrade |
Free Cash Flow Margin | 7.23% | 12.16% | 27.46% | 4.81% | -4.97% | 4.47% | Upgrade |
Free Cash Flow Per Share | 1.24 | 2.08 | 4.84 | 1.38 | -1.21 | 0.96 | Upgrade |
Cash Interest Paid | 1.38 | 1.68 | 3.46 | 2.91 | 2.56 | 3.1 | Upgrade |
Cash Income Tax Paid | 52.88 | 52.59 | 90.15 | 94.2 | 133.69 | 48.67 | Upgrade |
Levered Free Cash Flow | 87.1 | 150.34 | 357.75 | -14.93 | -141.04 | 175.53 | Upgrade |
Unlevered Free Cash Flow | 87.94 | 151.35 | 359.87 | -13.06 | -139.4 | 177.54 | Upgrade |
Change in Working Capital | 20.26 | 79.78 | 356.02 | -236.95 | -237.07 | -96.55 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.